Clinical Trial Update: HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an HPV vaccine therapy to reduce high-grade cervical lesions in patients with HIV; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• High-grade Cervical Squamous Intraepithelial Lesion

Drugs mentioned

• HPV vaccine therapy

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: AIDS-Related Human Papillomavirus Infection, High Grade Cervical Squamous Intraepithelial Neoplasia | Phase 3 | Status: COMPLETED